Last reviewed · How we verify
NCT06615518
Comparison of Clinical Effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in Patients With Lumbar Disc Herniation
NA trial testing transforaminal endoscopic lumbar discectomy in Lumbar Degenerative Disease in 220 participants. Participants enrolled and being followed up; not accepting new ones.
12 January 2025
Quick facts
| Lead sponsor | University of Opole |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 220 |
| Start date | 1 March 2024 |
| Primary completion | 12 January 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 2 locations across Poland |
Drugs / interventions tested
- transforaminal endoscopic lumbar discectomy
- Interlaminar endoscopic lumbar discectomy
- Microdiscectomy
Conditions studied
- Lumbar Degenerative Disease — all drugs for Lumbar Degenerative Disease →
- Lumbar Radiculopathy — all drugs for Lumbar Radiculopathy →
- Sciatic Leg Pain — all drugs for Sciatic Leg Pain →
- Sciatic Nerve Compression — all drugs for Sciatic Nerve Compression →
Sponsor
University of Opole
Who can join
Adults 18 to 85, any sex, with Lumbar Degenerative Disease or Lumbar Radiculopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the clinical effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in patients aged 18-85 with single-level lumbar disc herniation who have not undergone prior lumbar surgery. This study also aims to perform a radiological analysis of MRI scans before and after treatment to optimize patient selection and surgical strategies. The main questions it aims to answer are: * Does FELD provide superior early postoperative pain relief (measured by VAS) compared to MD? * Does FELD offer better functional recovery (measured by COMI and ODI scores) postoperatively compared to MD? * Can radiological analysis of pre- and post-operative MRI images help optimize patient qualification and guide surgical strategies? Researchers will compare patients undergoing FELD to those undergoing MD to see if endoscopic techniques result in faster recovery and lower early postoperative pain while maintaining similar long-term outcomes. The study will also analyze how MRI findings correlate with clinical outcomes to refine operative decision-making. Participants will: * Undergo either FELD or MD surgery * Complete VAS, COMI, and ODI questionnaires at pre-specified follow-up intervals (1, 3, 6, and 12 months post-surgery) * Have MRI scans 24 hours before surgery, 24 hours after surgery, and at each follow-up to assess disc recurrence, residual pathology, and to optimize surgical strategies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Tissue engineering strategies for treating intervertebral disc degeneration.
Nie G, Liu W, Zeng F, Hu J, et al · · 2025 · cited 2× · PMID 40727644 · DOI 10.3389/fbioe.2025.1582189
Verify or expand the search:
- PubMed search for NCT06615518
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lumbar Degenerative Disease
Currently open trials in the same condition.
- NCT07127380 — Comparison of Clinical Outcomes, Complications Rate and Treatment Costs of Mini-TLIF and MIDLIF in the Treatment of Disc · NA · recruiting
- NCT06650046 — Study on Topping-off Technique for Treating LDD · NA · recruiting
- NCT06940453 — CONDUIT™ Anterior Lumbar Interbody Fusion (ALIF) Cage System in Lumbar Degenerative Disease · recruiting
- NCT06904898 — CONDUIT vs. PEEK Cages · NA · active not recruiting
- NCT06989632 — Total Lumbar Disc Prosthesis and Subsequent Work Activity at at Least Five Years After Total Lumbar Disc Replacement · recruiting
Other University of Opole trials
Trials by the same sponsor.
- NCT07210281 — Osteogenon in Orthopedics and Traumatology · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06615518 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Opole
- Last refreshed: 20 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06615518.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing